FAB1561P

antibody from R&D Systems

Targeting: CD274 B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1

Flow cytometry (Recommended by provider)

Antibody Data

Product number

FAB1561P

Provider

R&D Systems

Product name

Anti-Human B7-H1/PD-L1 PE-conjugated Monoclonal Antibody (Clone 130021)

Antibody type

Monoclonal

Antigen

Mouse myeloma cell line NS0-derived recombinant human B7‑H1/PD‑L1, Phe19-Thr239

Description

Protein A or G purified from hybridoma culture supernatant

Reactivity

Human

Host

Mouse

Conjugate

Yellow dye

Antigen sequence

Q9NZQ7


Isotype

IgG

Vial size

100 Tests

References

Submitted references

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab.

Nicolazzo C, Raimondi C, Mancini M, Caponnetto S, Gradilone A, Gandini O, Mastromartino M, Del Bene G, Prete A, Longo F, Cortesi E, Gazzaniga P
Scientific reports 2016 Aug 24;6:31726

---

Frequent expression of PD-L1 on circulating breast cancer cells.

Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L, Rossille D, Maudelonde T, Fest T, Alix-Panabières C
Molecular oncology 2015 Nov;9(9):1773-82